Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. (Q48009320)

7 February 2018

title

Protective duration of immunity of an inactivated bluetongue (BTV) serotype 2 vaccine against a virulent BTV serotype 2 challenge in sheep. (English)

1 reference

7 February 2018

author name string

C Hamers

1

1 reference

7 February 2018

S Rehbein

2

1 reference

7 February 2018

P Hudelet

3

1 reference

7 February 2018

M Blanchet

4

1 reference

7 February 2018

B Lapostolle

5

1 reference

7 February 2018

C Cariou

6

1 reference

7 February 2018

M Duboeuf

7

1 reference

7 February 2018

S Goutebroze

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

10 March 2009

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

27

1 reference

7 February 2018

issue

21

1 reference

7 February 2018

page(s)

2789-2793

1 reference

7 February 2018

Physicochemical and morphological relationships of some arthropod-borne viruses to bluetongue virus--a new taxonomic group. Electron microscopic studies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

The epidemiology of bluetongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

The transmission and geographical spread of African horse sickness and bluetongue viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Culicoides biting midges: their role as arbovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

The epidemiology of bluetongue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Will bluetongue come on the wind to the United Kingdom in 2007?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Assessing the risk of windborne spread of bluetongue in the 2006 outbreak of disease in northern Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Bluetongue in the United Kingdom and northern Europe in 2007 and key issues for 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Bluetongue around the Mediterranean in 2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

The re-emergence of bluetongue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Bluetongue virus in the Mediterranean Basin 1998-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Re-emergence of bluetongue in northern Europe in 2007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Bluetongue Epidemiology in the European Union

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

7 January 2021

Vaccines for bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Differentiation between field and vaccine strain of bluetongue virus serotype 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Vaccines against bluetongue in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Protective efficacy of virus-like particles for bluetongue disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

Recombinant virus vaccine for bluetongue disease in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.099

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.02.099

1 reference

7 February 2018

PubMed ID

19366576

1 reference

7 February 2018